Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

Worrell said the treatment process for breast cancer takes anywhere from three to six months. It took her friend years to ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Kuehne+Nagel announced the opening of a new, temperature-controlled fulfilment centre for its partner, Medtronic. The global ...

12 ceremony. Axonics Inc. (Nasdaq: AXNX), a maker of medical devices to treat incontinence, said a jury has returned a ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

The company published trial design and preliminary data from the adaptive DBS algorithm for personalised therapy in Parkinson’s disease (ADAPT-PD) trial.